DOCSLIB.ORG

D494d197 90Ab 4Bfa A1c0

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
D494d197 90Ab 4Bfa A1c0 Dr. AGARWAL’S EYE HOSPITAL LIMITED NOTICE TO SHAREHOLDERS NOTICE IS HEREBY GIVEN that the 22nd Annual General Meeting of the shareholders of the company will be held on Tuesday, August 23rd 2016 at 11.00 am at No 19 (Old no 13), Cathedral Road, Chennai 600086 to transact the following business. ORDINARY BUSINESS: 1. To receive, consider and adopt the Balance Sheet as at March 31, 2016 and statement of Profit and Loss for the year ended on that date, the Report of the Directors and Auditor’s thereon. 2. To declare dividend on Equity Shares. 3. To appoint a Director, in place of Dr. Adil Agarwal (DIN: 01074272) who retires by rotation and being eligible, offers himself for re-appointment. 4. To appoint a Director, in place of Dr. Anosh Agarwal (DIN: 02636035) who retires by rotation and being eligible, offers himself for re-appointment. 5. To ratify the appointment of Statutory Auditors and if thought fit, to pass with or without modification(s) the following resolution as an Ordinary Resolution “RESOLVED THAT pursuant to Section 139 and all other applicable provisions of the Companies Act, 2013 read with the Companies (Audit and Auditors) Rules, 2014, the members of the Company do hereby ratify the appointment of M/s Deloitte Haskins and Sells (Firm Reg. No 008072S) Chartered Accountants, Chennai, as statutory auditors of the Company to hold office up to the conclusion of 26th Annual General Meeting of the Company, who were appointed in the 21st Annual General Meeting (held on September 10, 2015) for a period of five years till the conclusion of the 26th Annual General Meeting, on such remuneration and out of pocket expenses as may be determined by the Audit Committee and fixed by the Board of Directors of the Company.” SPECIAL BUSINESS: 6. Ratification of Remuneration to Cost Auditor for the Year 2015-16 To consider and if thought fit, to pass with or without modification(s), the following Resolution as anOrdinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 148 and other applicable provisions, if any, of the Companies Act, 2013 and The Companies (Audit and Auditors) Rules, 2014 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force), the remuneration payable for the year 2015-16 to Mr. P. Raju Iyer, Cost Accountant (Membership No: 6987) appointed by the Board of Directors of the Company to conduct the audit of the cost records of the Company for the financial year 2015-16, amounting to a remuneration of ` 60,000 plus service tax and re-imbursement of out of pocket expenses incurred by him in connection with the aforesaid audit be and is hereby ratified and confirmed.” 7. Re-Appointment Of Dr. AMAR AGARWAL (DIN: 00435684) As a Chairman Cum Managing Director To consider and if thought fit, to pass with or without modification, the following Resolution as Speciala Resolution: “RESOLVED THAT in accordance with the provisions of Sections 196, 197 and other applicable provisions of the Companies Act, 2013 (the Act), read with Schedule V to the Act and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 approval of the Members be and is hereby accorded to the re-appointment of Dr. Amar Agarwal (DIN 00435684) as a Chairman Cum Managing Director of the Company, (not liable to retire by rotation), for a period of three years, with effect from 1st October 2016 up to 30th September 2019 on a remuneration of not exceeding ` 7,00,000/- (Rupees Seven Lakhs only) per month.” “RESOLVED FURTHER THAT the remuneration as aforesaid shall be payable to the Chairman Cum Managing Director as the minimum remuneration, in the event of loss or inadequacy of profits in any financial year during the above said period, notwithstanding the limits laid down in Section 197 of the Companies Act, 2013.” 8. Re-Appointment Of Dr. (Mrs.) ATHIYA AGARWAL (DIN: 01365659) As a Whole-Time Director To consider and if thought fit, to pass with or without modification, the following Resolution as Speciala Resolution: RESOLVED THAT in accordance with the provisions of Sections 196, 197 and other applicable provisions of the Companies Act, 2013 (the Act), read with Schedule V to the Act and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 approval of the Members be and is hereby accorded to the re-appointment of Dr. Athiya Agarwal (DIN 01365659) as a Whole-Time Director of the Company, liable to retire by rotation, for a period of three years, with effect from 1st October 2016 up to 30th September 2019 on a remuneration of not exceeding ` 7,00,000/- (Rupees Seven Lakhs only) per month. “RESOLVED FURTHER THAT the remuneration as aforesaid shall be payable to the Whole-Time Director as the minimum remuneration, in the event of loss or inadequacy of profits in any financial year during the above said period, notwithstanding the limits laid down in Section 197 of the Companies Act, 2013.” 4 Dr. AGARWAL’S EYE HOSPITAL LIMITED 9. DELIVERY OF DOCUMENTS To consider and if thought fit to pass, with or without modification, the following resolution as anOrdinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 20 and all other applicable provisions of the Companies Act, 2013 (“the Act”) read with the Rules framed thereunder (“the Rules”) (including any statutory modification(s) or re-enactment(s) of the Act and/ or the Rules for the time being in force) authority be and is hereby given to the Board of Directors of the Company and any Committee which the Board of Directors may hereafter constitute for the time being for exercising the powers conferred on the Board of Directors by this Resolution) to determine the fee to be charged from member(s) who requests delivery of any document through a particular mode.“ For and on behalf of the Board Sd/- Place : Chennai Dr. Amar Agarwal Date : May 19, 2016 Chairman Cum Managing Director NOTES:- 1. The Statement pursuant to Section 102 (1) of the Companies Act, 2013, relating to the Special Business set out in the Notice is annexed. 2. A MEMBER OF THE COMPANY, WHO IS ENTITLED TO ATTEND AND VOTE AT THE MEETING, IS ENTITLED TO APPOINT A PROXY TO ATTEND AND VOTE INSTEAD OF HIM / HER AND THE PROXY NEED NOT BE A MEMBER. 3. Instrument of Proxies, in order to be effective, must be received at the Company’s Registered Office not later than 48 (Forty Eight) hours before the time fixed for holding the Annual General Meeting. A Form of Proxy for the AGM is enclosed. 4. The Register of Directors and Key Managerial Personnel (KMPs) and their shareholding, maintained under Section 170 of the Companies Act, 2013, will be available for inspection by the members at the AGM. 5. Register of Contracts or Arrangements in which Directors are interested, maintained under Section 189 of the Companies Act, 2013 will be available for inspection by the members at the AGM. 6. The Register of members and the share transfer books of the company will remain closed from August 17, 2016 to August 23, 2016 (both days inclusive) for the purpose of payment of the final dividend for the financial year ended March 31, 2016. 7. Dividend if declared, will be paid to the Members whose names appear on the Register of Members as on August 23rd, 2016 for shares held in physical mode and in respect of shares held in Electronic Form, to the beneficial owners, as per list that will be furnished by National Securities Depository Limited/ Central Depository Services (India) Limited, as on August 16th 2016. 8. Members are requested to notify immediately, changes in their respective addresses through their registered email address, if any, quoting their folio number so that the dividend warrants are correctly despatched. 9. Shareholders / proxy holders are requested to bring their copy of the annual report with them at meeting and to produce at the entrance, the attached admission slip duly completed and signed, for admission to the meeting hall. 10. Members who hold their shares in electronic mode are requested to direct change of address notifications and updates of saving bank account details to their DPs. Members are encouraged to utilize the Electronic Clearing System (ECS) for receiving dividends. 11. Members are requested to write to the Registrar and Share Transfer Agents of the Company, M/s Integrated Enterprises (India) Limited, Chennai for more information, if any needed, on Nomination facility and/ or to get a copy of Nomination Form, for shares held in physical mode. For shares held in demat mode, Members are requested to contact their respective Depository Participant for availing Nomination facility. 12. Members desirous of getting any information about the accounts and operation of the company are requested to address their query to the company at the Registered Office of the company well in advance so that the same may reach at least seven days before the date of meeting to enable the management to keep the required information readily available at the meeting. 5 Dr. AGARWAL’S EYE HOSPITAL LIMITED 13. Under the provisions of Section 205 A of the Companies Act, 1956 (Section 124 of the Companies Act, 2013, dividends remaining unpaid for a period of 7 years will be transferred to the Investor Education and Protection Fund (IEP Fund) of the Central Government. It may also be noted that once the unclaimed dividend is transferred to IEP Fund, no claim shall lie in respect thereof. Hence, the members who have not claimed their dividend relating to the earlier years may write to the Company or Share Transfer Agent for claiming the amount before it is transferred to the Fund.
Load more

Recommended publications
  • 5267830313.Pdf
    DR. AGARWAL’S EYE HOSPITAL LIMITED 1 CONTENTS Page No. Company Information 2 Financial Highlights 3 Notice to Shareholders 4 Directors’ Report 11 Management Discussion and Analysis 15 Corporate Governance Report 15 Auditors’ Certificate on Corporate Governance 26 Independent Auditors’ Report to the Members 28 Secretarial Compliance Certificate 32 Balance Sheet 36 Profit and Loss Account 37 Cash Flow Statement 38 Notes on Financial Statement 41 Attendance Slip and Proxy Form 59 2 DR. AGARWAL’S EYE HOSPITAL LIMITED COMPANY INFORMATION Board of Directors Dr. Amar Agarwal (Chairman cum Managing Director) Dr. Athiya Agarwal (Wholetime Director) Dr. Adil Agarwal (Wholetime Director) Dr. Anosh Agarwal (Wholetime Director) Dr. Jasvinder Singh Saroya Mr. M. R. G. Apparao Mr. Prabhat Toshniwal Mr. Sanjay Anand Auditors M/s. M. K. Dandeker & Co. Chartered Accountants, 244, Angappa Naicken Street, Chennai 600 001. Registered Office 19 (Old No.13), Cathedral Road, Chennai 600 086. Bankers (1) State Bank of India, Gopalapuram Branch, Chennai - 600 086. (2) State Bank of India, Industrial Finance Branch, Chennai 600 002. Share Transfer Agents Integrated Enterprises (India) Ltd. 2nd Floor, Kences Towers, No.1, Ramakrishna Street, North Usman Road, T.Nagar, Chennai 600 017. Tel: 2814 0801-03 Email: [email protected] DR. AGARWAL’S EYE HOSPITAL LIMITED HOSPITAL EYE AGARWAL’S DR. Financial Highlights Rs. in crore For the year ended 2012-13 2011-12 2010-11 2009-10 2008-09 2007-08 2006-07 2005-06 2004-05 2003-04 Total Income 109.73 105.68 104.01
    [Show full text]
  • Agarwal AR 19.Indd
    Contents Page No Chairman’s Desk 3 Board of Directors 5 A Word from Chairman - Clinical Board 9 Industrial Update 12 Notice to Shareholders 15 Directors’ Report 29 Management Discussions and Analysis Report 46 Corporate Governance Report 50 A word from the CFO 61 Financial Highlights 62 Independent Auditor’s Report 65 Balance Sheet as at 31st March, 2019 72 Statement of Profit and Loss for the year ended 31st March 2019 73 Statement of changes in equity for the year ended 31st March 2019 74 Cash Flow Statement as on 31st March 2019 75 Notes Forming Part of the Financial Statements for the year ended 76 31st March 2019 Press Clippings 120 NABH Accredited 126 Route map to AGM venue 128 CORPORATE Chairman’s INFORMATION Desk DIRECTORS Dr. Amar Agarwal (DIN: 00435684) ..................... Chairman Cum Managing Director Dr. Athiya Agarwal (DIN: 01365659) .................... Whole-time Director Dr. Adil Agarwal (DIN: 01074272) ........................ Director Mr. Sanjay Anand (DIN: 02501139) ...................... Independent Director Mr T. R. Ramasubramanian (DIN: 08207929) ........ Independent Director Mrs. Lakshmmi Subramanian (DIN: 00001439) .... Independent Director CHIEF FINANCIAL OFFICER Dear Shareholders, Ms. Saradha Govindarajan I look back nearly 60 years to when we initially set out to build the first Eye care hospital under our name, and then to the journey thereafter, in nurturing it into the world-class Eye care institution it COMPANY SECRETARY & COMPLIANCE OFFICER has grown into today. Now the hospital chain in its 62nd year of service has a total presence of 22 Ms. Jully H. Jivani hospitals across India. Our motivation for the pursuit of our goals has not wavered a bit through this eventful and challenging journey.We believe we are best suited to lead the eye care space in the AUDITORS coming years M/s.
    [Show full text]
  • Visually Significant Traumatic Cataract
    CATARACT SURGERY COMPLEX CASE MANAGEMENT Section Editors: Thomas A. Oetting, MS, MD; Tal Raviv, MD; and Audrey R. Talley Rostov, MD eyetube.net Visually Significant Traumatic Cataract BY PRIYA NARANG, MS; AMAR AGARWAL, MS, FRCS, FRCOPHTH; H. BURKHARD DICK, MD, PHD; TIM SCHULTZ, MD; RICHARD J. MACKOOL, MD; RICHARD J. MACKOOL JR, MD; AND TAL RAVIV, MD CASE PRESENTATION A 50-year-old man presents with a visually significant (Courtesy of Priya Narang, MS, and Amar Agarwal, FRCS, FRCOphth.) traumatic cataract (following blunt trauma 5 years ago). About 7 clock hours of zonular loss (Figure 1) and phaco- donesis are present. Small wisps of vitreous are visible at the edge of the lens. How would you approach this case? —Case prepared by Tal Raviv, MD. (Courtesy of Tal Raviv, MD.) Figure 2. The design of the glued ECR and its positioning in the direction of dialysis. the hemi-ring segment portion and are designed to sit Figure 1. A traumatic cataract with 7 clock hours of zonu- within the fornix of the capsular bag. The scrolls engage lar loss and mild vitreous prolapse in a young patient. the margin of the capsulorhexis, and the haptic anchors the entire bag transsclerally (Figure 2). Once the scrolls PRIYA NARANG, MS, AND have engaged the capsulorhexis’ margin, pulling on the AMAR AGARWAL, MS, FRCS, FRCOPHTH exteriorized haptic centers the entire capsular bag com- Figure 1 shows traumatic subluxation of the lens with plex. Phacoemulsification then commences. The choice 7 clock hours of zonular loss. The clinical picture is sug- and positioning of the IOL depend on the degree and gestive of phacodonesis, and small wisps of vitreous are location of zonular disruption.
    [Show full text]
  • REFRACTIVE Laser
    4 Cover Story REFRACTIVE Laser QUEST FOR PERFECTION LASIK banks on mature technology and reduced complication rates to stay ahead of the competition by Dermot McGrath aser-assisted in situ how many patients fall under the terminally complication rates in recent years. keratomileusis (LASIK) has dissatisfied category over the long term, the “There has definitely been an been assessed and improved by fact that the FDA in the US received just improvement over the past few years which I still believe many more than a decade of clinical 140 “negative reports relating to LASIK” I would attribute to improved technology, “patients disappear studiesL and technological innovation since for the time period 1998-2006 suggests to with better preoperative diagnostics and from their surgeon’s the procedure was first introduced. As some observers that LASIK complication also much better patient screening in terms practices after the one one of the most popular elective surgical and/or dissatisfaction rates are probably of anterior and posterior surface, corneal year of ‘free’ follow- procedures in the world, with one of the under-reported. thickness, and even family history to help up care that most highest safety profiles, LASIK remains the A 2008 study on LASIK complications prevent complications such as post-LASIK provide. Consequently, primary dynamo driving today’s global carried out at Wills Eye Institute (J ectasia,” said Francesco Carones MD, refractive surgery market. Cataract Refract Surg. 2008 Jan;34(1):32- Co-founder and medical director of the I do believe we have However, given the huge volume of 9.), for instance, found that only 29 per Carones Ophthalmology Centre in been underestimating procedures performed since its inception, cent of patients referred for problems Milan, Italy.
    [Show full text]
  • Model Curriculum Handbook
    Ministry of Health and Family Welfare Allied Health Section 2015-16 Model Curriculum Handbook OPTOMETRY Model Curriculum Handbook OPTOMETRY Ministry of Health and Family Welfare Allied Health Section Contents Contributors to drafting and review ............................................................................................................... 3 List of Abbreviations ..................................................................................................................................... 5 Chapter 1: Introduction to the Handbook.................................................................................................... 11 Who is an Allied and Healthcare Professional? ......................................................................................... 11 Scope and need for allied and healthcare professionals in the Indian healthcare system ............................ 11 Learning goals and objectives for allied and healthcare professionals ....................................................... 12 Introduction of new elements in allied and healthcare education .............................................................. 17 Competency-based curriculum ............................................................................................................. 17 Promoting self-directed learning of the professionals ........................................................................... 17 Credit hours vs traditional system .......................................................................................................
    [Show full text]
  • SHOULD LASIK BE REBRANDED? Experts Debate Whether the Leading Refractive Surgery Procedure Needs a New Name
    COVER FOCUS COVER POINT/COUNTERPOINT: SHOULD LASIK BE REBRANDED? Experts debate whether the leading refractive surgery procedure needs a new name. BY SOOSAN JACOB, MS, FRCS, DNB; AMAR AGARWAL, MS, FRCS, FRCOPHTH; MARC MULLIE, MD, FRCSC; MICHAEL LAWLESS, MBBS, FRANZCO, FRACS; DAN Z. REINSTEIN, MD, MA(CANTAB), FRCSC, DABO, FRCOPHTH, FEBO; VANCE THOMPSON, MD; AND J. TREVOR WOODHAMS, MD Point: refractive surgery procedure. The advantages that this tech- nique offers are numerous. For starters, the absence of a flap A LASIK Rebrand is in Order and the use of a small incision together act to eliminate flap- By Soosan Jacob, MS, FRCS, DNB; Amar Agarwal, MS, related complications such as striae, flap dislodgement, and FRCS, FRCOphth; and Marc Mullie, MD, FRCSC epithelial ingrowth. Similarly, because of decreased disruption of the anterior corneal innervation, there is faster recovery Rebrand Refractive Surgery of corneal sensitivity and less patient experience of dry eye by Introducing a New Procedure than is seen with LASIK.3 Most important, the presence of the Soosan Jacob, MS, FRCS, DNB; and nearly intact anterior stromal layer of the cornea allows better Amar Agarwal, MS, FRCS, FRCOphth maintenance of biomechanical strength after SMILE compared Corneal refractive surgery has evolved with LASIK.4,5 The entire procedure is completed with a single over the years, progressing through techniques from cuts in the cornea (RK), to excimer laser surface ablation (PRK), to intrastromal ablation under a flap (LASIK). The last of these approaches has been the most successful technique thus AT A GLANCE far, with widespread worldwide acceptance and penetration. WHAT YOUR PEERS ARE SAYING The LASIK flap itself has evolved, from being created with a ABOUT LASIK REBRANDING mechanical microkeratome to being cut with a femtosecond • Instead of rebranding LASIK specifically, it could be laser.
    [Show full text]
  • Image of the Month the Human Choroid, Reconstructed in 3D
    APRIL 2016 # 29 Image of the Month Upfront Profession Sitting Down With The human choroid, Growing your own Benchmarking your practice Amar Agarwal, Chairman of reconstructed in 3D crystalline lens against your peers Dr Agarwal’s Eye Hospital 03 08 – 10 60 – 64 66 – 67 www.theophthalmologist.com DUAL-SEGMENT PUMP TECHNOLOGY + Precise fluidics + Pulsatile-free + Quick vacuum rise + Versatile performance PERFORMANCE IN EVERY DETAIL Superior chamber stability through superior engineering.†,1,2 That’s the Centurion® Effect. Active Fluidics™ Technology • Helps to Maintain Chamber Stability: Detects and compensates to help provide superior chamber stability3 compared to INFINITI®4 • Less Surge: Less surge at any tested vacuum level3,5 • More Consistent IOP4 : Up to 80% less surge area3,5 Contact your Alcon representative to schedule a demonstration and experience the Centurion® Effect for yourself. †As compared to the INFINITI® Vision System, bottle gravity system. 1. Lorente R, Fanney D, Injev V, Sharif-Kashani P. Quantification of occlusion break surge in peristaltic-based phacoemulsification systems. ASCRS-ASOA Symposium and Congress; April 25-29, 2014; Boston, USA.2. Nicoli M, Miller K, Dimalanta R, Loke D; Jules Stein Eye Institute, UCLA. IOP Stability Measurement and Comparison Between Gravity-Fed and Actively Controlled Phacoemulsification Systems. 2014. 3. Sharif-Kashani P, Fanney D, Injev V. Comparison of occlusion break responses and vacuum rise times of phacoemulsification systems. BMC Ophthalmol. 2014;14:96. 4. Nicoli CM, Dimalanta R, Miller K. Experimental anterior chamber maintenance in active versus passive phacoemulsification fluidics systems. J Cataract Refract Surg. 2016;42(1):157-162. 5. Alcon data on file.
    [Show full text]
  • Educational Qualifications
    CURRICULUM VITAE PERSONAL NAME : Dr. Sunita Agarwal I have been fortunate to be born in a family of ophthalmologists. My grandfather Dr. Raghvir S. Agarwal was a noted ophthalmologist of his time in India. My father Dr. Jaivir Agarwal is the founder of Dr. Agarwal ‘s Eye Institute, Chennai, mother Dr. Mrs. Tahira Agarwal is also a renowned ophthalmic surgeon currently practicing as a corneal specialist. My brother Dr. Amar Agarwal and myself both are ophthalmic surgeons, extensively engaged in ophthalmic research, teaching are currently practicing with our parents at Chennai. Dr. Athiya Agarwal, wife of Dr Amar Agarwal is also a part of the team. EDUCATIONAL QUALIFICATIONS 1. COMPLETED MATRICULATION FROM SACRED HEART CHURCH PARK SCHOOL IN 1975 I had a complete childhood with schooling from one of the finest institutions in the country. As is well known convent education brings with it a flare to the child and close proximity with God. In any format the individual gets to think of the less fortunate and realizes the pain and anguish of our school teachers and convent nuns. I was extremely mischievous and was called out to the Principals office very often still in this developed a close camaraderie with my Principal Teacher Sister Clare. So much so that till today she remembers me fondly of tying my unruly hair in her own ribbons or admonishing me for one of my little crimes. I also happened to be the School pupil leader in the my last year occasion came on a day when I had just come back from Delhi after winning the national gold medal for swimming for 1974, and as I entered school the election had taken place in my absence, this was one of few times I saw tears (of joy) in my fathers year.
    [Show full text]
  • Sizing and Centering the Capsulorhexis by WILLIAM BOND, MD; BROCK K
    CATARACT SURGERY PHACO PEARLS Sizing and Centering the Capsulorhexis BY WILLIAM BOND, MD; BROCK K. BAKEWELL, MD; AMAR AGARWAL, MS, FRCS, FRCOPHTH; AND DAVID SPALTON, FRCS, FRCP, FRCOPHTH Most surgeons have performed the capsulorhexis since its groundbreaking, simultaneous introduction in 1990 by Thomas Neuhann, MD, and Howard Gimbel, MD.1 Now, as the use of aspheric and presbyopia-correcting IOLs becomes widespread, the sizing and centration of the capsulorhexis have never been more essential. Sufficiently sized for the intend- ed IOL and adequately centered, the capsulorhexis is the framework for the production of a stable postoperative IOL/bag complex and the achievement of excellent postoperative vision. How do surgeons optimize the capsulorhexis? —William J. Fishkind, MD, Section Editor WILLIAM BOND, MD tear reappears, of course, I redirect it parallel to the iris Over the years, I have favored a large capsulorhexis for and less peripherally. better access to the lens proper, because I believe that the The other common cause of extending a capsulorhex- anterior capsule is part of the cataract. In the event of a is too far is not to regrasp the tearing flap frequently posterior capsular rupture, there is virtually always enough. The tear will circumferentially expand as the enough anterior capsule to support a PCIOL in the sulcus, edge gets farther from the forceps. This scenario seems no matter how large the capsulorhexis was initially. Fur- elementary but can easily happen. A minimum of two thermore, it has been my experience that there are many regrabbings close to the tearing flap’s edge, after the ini- more longitudinal tears in the anterior capsule in the tial grab, is what I find easiest.
    [Show full text]
  • Press Release Dr. Agarwals Eye Hospital Limited
    Press Release Dr. Agarwals Eye Hospital Limited June 13, 2019 Rating Amount Facilities Rating1 Rating Action (Rs. crore) Long-term Bank Facilities - - Withdrawn Total Facilities - Details of facilities in Annexure-1 Detailed Rationale, Key Rating Drivers and Detailed description of the key rating drivers CARE has withdrawn the outstanding ratings of ‘CARE BBB+; Stable’ *Triple B Plus; Outlook: Stable+ assigned to the bank facilities of Dr. Agarwal’s Eye Hospital Limited (DAEHL) with immediate effect. The above action has been taken at the request of DAEHL and ‘No Objection Certificate’ received from the bank that has extended the facilities rated by CARE. Detailed description of the key rating drivers: At the time of last rating on December 04, 2018 following were the rating strengths and weaknesses (updated for the information available from BSE website): Key Rating Strengths Vast experience of the promoters in eye care services: DAEHL was promoted by Padma Bhushan late Dr J. Agarwal and his family members, who have been in the profession of providing eye care solutions for over five decades extending up to the third generation currently. His son, Dr Amar Agarwal, MBBS, MS, FRCS, FRC Ophth, the current Chairman and Managing Director, has over two decades of experience in the eye care sector. He handles the operations of the company on a day-to- day basis along with his wife, Dr Athiya Agarwal and his sons, Dr Adil Agarwal and Dr Anosh Agarwal. Established brand presence and long-operational track record: DAEHL has established itself as one of the leading eye care hospital chains in the Tamil Nadu region.
    [Show full text]
  • Mastering Phaco Nightmares and Worst Case Scenarios: a Video Based Course
    Mastering phaco nightmares and worst case scenarios: A video based course Prof Amar Agarwal MS, FRCS,FRCOphth POSTERIOR CAPSULAR RUPTURE Any breach in the continuity of the posterior capsule is defined as a posterior capsule tear. Intrasurgical posterior capsule tears are the most common and can occur during any stage of cataract surgery. The incidence of posterior capsule complications is related to the type of cataract and conditions of the eye, increases with the grade of difficulty of the case, and furthermore is influenced by the level of experience of the surgeon. Timely recognition and a planned management, depending upon the stage of surgery during which the posterior capsule tear has occurred, is required to ensure an optimal visual outcome. COMMON RISK FACTORS FOR POSTERIOR CAPSULAR RUPTURE (PCR): 1. Intraoperative factors causing variation in anterior chamber depth 2. Type of cataract 3. Extended rhexis Intraoperative factors causing variation in anterior chamber depth Intraoperative shallow anterior chamber could be due to various reasons. It may be a tight lid speculum, tight drapes, or pull from the recollecting bag. In all the above cases, remove the precipitating factor (Remove the speculum pressure, remove the tight drapes and collecting bags). Variation in the amount of space in the anterior and posterior chambers may result from changes in the intraocular pressure (IOP) due to an alteration in the equilibrium between inflow and outflow of fluid. Diminished inflow may be secondary to insufficient bottle height, tube occlusion or compression, bottle emptying, too tight incisions compressing the irrigation sleeve, or the surgeon moving the phaco tip out of the incision, making the irrigation holes come out of the incision.
    [Show full text]
  • Assisted Pre-Descemet Endothelial Keratoplasty
    Journal name: Clinical Ophthalmology Article Designation: Letter Year: 2015 Volume: 9 Clinical Ophthalmology Dovepress Running head verso: Jacob et al Running head recto: E-DMEK and E-PDEK open access to scientific and medical research DOI: http://dx.doi.org/10.2147/OPTH.S95282 Open Access Full Text Article LETTER Endoilluminator-assisted Descemet membrane endothelial keratoplasty and endoilluminator- assisted pre-Descemet endothelial keratoplasty Soosan Jacob1,2 Dear editor Amar Agarwal1 We read with great interest the article by Kobayashi et al on the use of endoillumination Dhivya Ashok Kumar1 probe-assisted Descemet membrane endothelial keratoplasty (DMEK) for bullous 1 1Dr Agarwal’s Eye Hospital and Eye keratopathy secondary to argon-laser iridotomy. We would like to bring to the author’s Research Centre, 2Dr Agarwal’s notice that one of us (SJ) described the use of external endoillumination for DMEK, Refractive and Cornea Foundation (DARCF), Chennai, India and the same was published under our names in 2014 as endoilluminator-assisted transcorneal illumination for DMEK,2 with study patients included from January 2013. There are also numerous other references to this online.3–6 We have termed this tech- nique endoilluminator-assisted DMEK or E-DMEK and endoilluminator-assisted pre- Descemet endothelial keratoplasty (E-PDEK) when applied to PDEK.7 E-DMEK makes the surgery simpler by allowing good visualization and better surgeon comprehension of graft morphology and dynamics and enhanced visualization and three-dimensional depth perception through edematous and hazy corneas (Figure 1). The technique also aids the surgeon with better comprehension of graft orientation and positioning (Video S1). We would like to gently bring to the authors’ attention that our work was the initial report on E-DMEK, and that this has been missed in their citation.
    [Show full text]